Drugs / BK-C-0701
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01258699 | Aug 2009 → ? | — | Bukwang Pharmaceutical | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01261143 | Aug 2010 → Apr 2012 | diabetic neuropathy | Bukwang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BK-C-0701 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01258699 ↗ |